ACCOLADE INC (ACCD) Stock Price, Quote, News and Overview
NASDAQ:ACCD - Nasdaq - US00437E1029 - Common Stock - Currency: USD
ACCD Quote, Performance and Key Statistics
7.02
-0.01 (-0.14%)
The current stock price of ACCD is 7.02 USD. In the past month the price increased by 0.86%. In the past year, price decreased by -14.91%.
ACCD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.55 | 84.87B | ||
| CI | THE CIGNA GROUP | 11.32 | 83.48B | ||
| LH | LABCORP HOLDINGS INC | 17.61 | 21.72B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.47 | 19.98B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 14.4 | 15.89B | ||
| HIMS | HIMS & HERS HEALTH INC | 85.86 | 13.26B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 121.53 | 13.13B | ||
| DVA | DAVITA INC | 14.77 | 10.31B | ||
| CHE | CHEMED CORP | 23.32 | 8.04B | ||
| GH | GUARDANT HEALTH INC | N/A | 6.14B | ||
| CRVL | CORVEL CORP | 56.41 | 5.27B | ||
| OPCH | OPTION CARE HEALTH INC | 25.68 | 5.21B |
Related stock screener links
About ACCD
Company Profile
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
Company Info
ACCOLADE INC
660 W. Germantown Pike Suite 500
Plymouth Meeting PENNSYLVANIA 98101 US
CEO: Rajeev Singh
Employees: 2400
Phone: 16108342989
ACCOLADE INC / ACCD FAQ
What is the stock price of ACCOLADE INC today?
The current stock price of ACCD is 7.02 USD. The price decreased by -0.14% in the last trading session.
What is the ticker symbol for ACCOLADE INC stock?
The exchange symbol of ACCOLADE INC is ACCD and it is listed on the Nasdaq exchange.
On which exchange is ACCD stock listed?
ACCD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ACCOLADE INC stock?
16 analysts have analysed ACCD and the average price target is 6.83 USD. This implies a price decrease of -2.7% is expected in the next year compared to the current price of 7.02. Check the ACCOLADE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ACCOLADE INC worth?
ACCOLADE INC (ACCD) has a market capitalization of 575.57M USD. This makes ACCD a Small Cap stock.
How many employees does ACCOLADE INC have?
ACCOLADE INC (ACCD) currently has 2400 employees.
What are the support and resistance levels for ACCOLADE INC (ACCD) stock?
ACCOLADE INC (ACCD) has a support level at 7 and a resistance level at 7.04. Check the full technical report for a detailed analysis of ACCD support and resistance levels.
Is ACCOLADE INC (ACCD) expected to grow?
The Revenue of ACCOLADE INC (ACCD) is expected to grow by 13.05% in the next year. Check the estimates tab for more information on the ACCD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ACCOLADE INC (ACCD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACCD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACCD, evaluating the profitability, health, valuation and growth aspects
- ACCOLADE INC (ACCD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACCOLADE INC (ACCD) Sales and EPS estimates to see what analysts future expectations are.
- ACCOLADE INC (ACCD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACCOLADE INC (ACCD) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACCOLADE INC (ACCD) Stock Chart to make your own analysis
- ACCOLADE INC (ACCD) Latest news and press-releases to stay up to date.
Does ACCOLADE INC (ACCD) stock pay dividends?
ACCD does not pay a dividend.
When does ACCOLADE INC (ACCD) report earnings?
ACCOLADE INC (ACCD) will report earnings on 2025-04-23, after the market close.
What is the Price/Earnings (PE) ratio of ACCOLADE INC (ACCD)?
ACCOLADE INC (ACCD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).
ACCD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ACCD. When comparing the yearly performance of all stocks, ACCD turns out to be only a medium performer in the overall market: it outperformed 44.41% of all stocks.
ACCD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACCD. The financial health of ACCD is average, but there are quite some concerns on its profitability.
ACCD Financial Highlights
Over the last trailing twelve months ACCD reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS increased by 35.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.85% | ||
| ROE | -57.6% | ||
| Debt/Equity | 0.67 |
ACCD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 54% to ACCD. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -8.14% and a revenue growth 13.05% for ACCD